Breaking News Instant updates and real-time market news.

LEA

Lear

$118.05

0.34 (0.29%)

, GM

General Motors

$37.42

-0.2 (-0.53%)

08:19
09/30/19
09/30
08:19
09/30/19
08:19

Lear price target lowered to $150 from $160 at KeyBanc

KeyBanc analyst James Picariello lowered his price target for Lear (LEA) to $150 from $160 as he expects the company to reduce its guidance as a result of the General Motors (GM)/UAW strike impact. Further, he would not be surprised to see the shares facing some pressure from the "headline cut," but would be a buyer of any weakness. The analyst reiterates an Overweight rating on Lear's stock.

LEA

Lear

$118.05

0.34 (0.29%)

GM

General Motors

$37.42

-0.2 (-0.53%)

LEA Lear
$118.05

0.34 (0.29%)

07/17/19
SBSH
07/17/19
DOWNGRADE
Target $144
SBSH
Neutral
Lear downgraded to Neutral from Buy at Citi
Citi analyst Itay Michaeli downgraded Lear (LEA) to Neutral from Buy and lowered his price target on the stock to $144 from $188 following the company's 2019 guidance cut, which he contends "might not be fully explained by macro alone." Given the double-digit percentage cut to Lear's FY19 net income outlook, the reaction in the stock today "appears rather mild," said the analsyt, who added that the guidance cut suggests to him a worsening of some of the E-Systems revenue issues he'd previously called out. On the surface, the news appears to have a negative-read for suppliers with heavy exposure in Europe and China - such as Visteon (VC), Autoliv (ALV), Veoneer (VNE), BorgWarner (BWA) and Aptiv (APTV) - but Michaeli reiterated that he thinks there are also company-specific factors in play.
07/29/19
FBCO
07/29/19
NO CHANGE
Target $130
FBCO
Neutral
Lear price target lowered to $130 from $155 at Credit Suisse
Credit Suisse analyst Dan Levy lowered his price target for Lear to $130 from $155 saying that e-systems challenges are "emblematic of pivot from Lear 1.0 to Lear 2.0." The analyst reiterates a Neutral rating on the shares.
09/12/19
UBSW
09/12/19
DOWNGRADE
UBSW
Neutral
Lear downgraded to Neutral from Buy at UBS
09/12/19
UBSW
09/12/19
DOWNGRADE
UBSW
Neutral
Visteon, Adient, Lear downgraded at UBS on rising recession risk
UBS analyst Colin Langan downgraded Adient (ADNT) and Lear (LEA) to Neutral from Buy and Visteon (VC) to Sells from Neutral as part of a broader sector research note. The analyst says he was previously bullish on the group in hopes of easing trade tensions, which are "not looking good now", and the prospects of a China recovery, which looks "even worse". In addition to these factors, the industry has faced negative news around "surprising margin weakness", risks of increased price concessions, and rising recession possibility. Langan notes that despite these headwinds, U.S. auto suppliers are still up 25% year-to-date even though the average 2019 earnings estimates on the group are down 22%. As part of the downgrade, the analyst cut his Adient price target to $27 from $30, Lear to $135 from $158, and Visteon to $61 from $66.
GM General Motors
$37.42

-0.2 (-0.53%)

09/16/19
09/16/19
UPGRADE
Target $15

Buy
Cars.com upgraded to Buy on attractive valuation, GM approval at Craig-Hallum
As previously reported, Craig-Hallum analyst Steve Dyer upgraded Cars.com (CARS) to Buy from Hold, with a $15 price target, as he thinks shares are mostly de-risked following the "massive" selloff after the conclusion of the company's strategic review. Further, the analyst believes that estimate cuts are largely done for the first time since the spin-out, and thinks the company's "strong" free cash flow is underappreciated. The announcement by General Motors (GM) to approve Dealer Inspire as an optional website services provider for its 4k dealers could be a catalyst for shares, he adds.
09/19/19
LOOP
09/19/19
NO CHANGE
Target $104
LOOP
Buy
Ingevity fundamentals not undermined by UAW strike, says Loop Capital
Loop Capital analyst Chris Kapsch keeps his Buy rating and $104 price target on Ingevity (NGVT), saying the underpinnings of his recent upgrade remain intact even though the stock price has pulled back about 4% over the past few days. The analyst notes that the retreat was likely driven by concerns about General Motors' (GM) UAW strike and the attempts by the Trump administration to revoke auto emission regulation in California, but believes that these developments do not alter the overall fundamental story for the stock. Kapsch adds that he would be inclined to buy into any additional pressure on Ingevity shares.
09/23/19
BUCK
09/23/19
NO CHANGE
Target $35
BUCK
Neutral
GM likely to face longer-term work stoppage as strike drags on, says Buckingham
Buckingham analyst Joseph Amaturo maintained a Neutral rating and $35 price target on GM as the UAW strike enters its second week and reiterated his view that an extended stoppage is "likely." In a research note to investors, Amaturo says he believes GM has "no choice" but to settle for unfavorable terms, as political consensus has firmly sided with the UAW workers publicly, granting them sympathy and the moral high ground from President Trump and the Democrats. With the stock trading lower by just under 4% last week, the analyst says he believes that the shares could come under additional pressure as investors realize that this will be a longer-term work stoppage after one full week of negotiating without a settlement.
09/30/19
OPCO
09/30/19
NO CHANGE
OPCO
Potential value of Tesla emissions credits 'underappreciated,' says Oppenheimer
With Tesla (TSLA) reporting Q3 deliveries this week, Oppenheimer analyst Colin Rusch believes the company is working aggressively to reach its fiscal year 2019 volume guidance of 360k-400k units. If it achieves 100k deliveries in Q3, it would need 101.7k vehicles to reach the low end of that guidance, which he believes is ahead of Street expectations. Rusch also thinks demand in Europe remains strong, driven partially by emissions regulations, and believes investors underappreciate the potential value of Tesla emissions credits as OEMs continue to lag schedules for new energy vehicle availability. At the same time, the analyst continues to watch the impact of General Motors' (GM) strike, as he believes many of the issues facing the company are endemic in the industry and sees the issues for legacy OEMs helping extending Tesla's window of opportunity for taking share.

TODAY'S FREE FLY STORIES

11:06
11/19/19
11/19
11:06
11/19/19
11:06
General news
8-Week Bill Announcement Offering Amount data reported »

8-Week Bill Announcement…

11:06
11/19/19
11/19
11:06
11/19/19
11:06
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

MDCO

The Medicines Co.

$69.90

11.24 (19.16%)

, NVS

Novartis

$90.20

-0.08 (-0.09%)

11:06
11/19/19
11/19
11:06
11/19/19
11:06
Recommendations
The Medicines Co., Novartis analyst commentary  »

JPMorgan says Medicines…

MDCO

The Medicines Co.

$69.90

11.24 (19.16%)

NVS

Novartis

$90.20

-0.08 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PDD

Pinduoduo

$40.14

-1.41 (-3.39%)

11:05
11/19/19
11/19
11:05
11/19/19
11:05
Options
Pinduoduo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

VRTX

Vertex

$213.24

3.23 (1.54%)

, CRSP

Crispr Therapeutics

$72.97

14.45 (24.69%)

11:03
11/19/19
11/19
11:03
11/19/19
11:03
Recommendations
Vertex, Crispr Therapeutics analyst commentary  »

Cantor boosts Vertex…

VRTX

Vertex

$213.24

3.23 (1.54%)

CRSP

Crispr Therapeutics

$72.97

14.45 (24.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 07

    Dec

  • 19

    Mar

W

Wayfair

$84.93

-1.5 (-1.74%)

, AMZN

Amazon.com

$1,751.03

-1.67 (-0.10%)

10:57
11/19/19
11/19
10:57
11/19/19
10:57
Periodicals
Citron accuses Wayfair of lying, says shares headed to $45 »

Andrew Left's Citron…

W

Wayfair

$84.93

-1.5 (-1.74%)

AMZN

Amazon.com

$1,751.03

-1.67 (-0.10%)

RH

RH

$181.50

-6.08 (-3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 19

    Dec

MCS

Marcus

$33.79

0.305 (0.91%)

10:57
11/19/19
11/19
10:57
11/19/19
10:57
Conference/Events
Benchmark services/entertainment analysts hold analyst/industry conference call »

Consumer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

SPY

SPDR S&P 500 ETF Trust

$311.90

-0.11 (-0.04%)

10:50
11/19/19
11/19
10:50
11/19/19
10:50
Options
Massive collar trade in SPY tied to 4M shares suggests sentiment shift »

Massive collar trade in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
11/19/19
11/19
10:50
11/19/19
10:50
General news
Treasury Action: yields are extending lower as stocks sag »

Treasury Action: yields…

W

Wayfair

$84.99

-1.44 (-1.67%)

10:48
11/19/19
11/19
10:48
11/19/19
10:48
Hot Stocks
Breaking Hot Stocks news story on Wayfair »

Wayfair shares down 2% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

W

Wayfair

$84.99

-1.44 (-1.67%)

10:48
11/19/19
11/19
10:48
11/19/19
10:48
Periodicals
Breaking Periodicals news story on Wayfair »

Citron Research puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

W

Wayfair

$84.99

-1.44 (-1.67%)

10:48
11/19/19
11/19
10:48
11/19/19
10:48
Periodicals
Breaking Periodicals news story on Wayfair »

Citron Research puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

CDE

Coeur Mining

$6.69

0.055 (0.83%)

10:45
11/19/19
11/19
10:45
11/19/19
10:45
Options
Coeur Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
11/19/19
11/19
10:45
11/19/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

10:45
11/19/19
11/19
10:45
11/19/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

10:40
11/19/19
11/19
10:40
11/19/19
10:40
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

HCM

Hutchison China MediTech

$23.59

(0.00%)

10:33
11/19/19
11/19
10:33
11/19/19
10:33
Initiation
Hutchison China MediTech initiated  »

Hutchison China MediTech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$35.16

-2.72 (-7.18%)

10:30
11/19/19
11/19
10:30
11/19/19
10:30
Options
Selloff in Nordstrom's prompts vertical put spread to roll position »

Selloff in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

  • 05

    Dec

HOG

Harley-Davidson

$37.03

-0.535 (-1.42%)

10:28
11/19/19
11/19
10:28
11/19/19
10:28
Conference/Events
UBS leisure/finance analysts to hold an analyst/industry conference call »

Leisure Analyst Farley…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSOD

Cornerstone OnDemand

$59.41

-0.05 (-0.08%)

10:27
11/19/19
11/19
10:27
11/19/19
10:27
Periodicals
Cornerstone OnDemand a candidate for activist pressure, Dealreporter says »

Cornerstone OnDemand,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 21

    Nov

NCR

NCR Corp.

$33.52

-0.08 (-0.24%)

10:25
11/19/19
11/19
10:25
11/19/19
10:25
Conference/Events
NCR Corp. management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

TLRY

Tilray

$20.11

0.23 (1.16%)

10:25
11/19/19
11/19
10:25
11/19/19
10:25
Options
Tilray call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$60.85

1.31 (2.20%)

10:24
11/19/19
11/19
10:24
11/19/19
10:24
Recommendations
TJX analyst commentary  »

TJX reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 05

    Dec

NCR

NCR Corp.

$33.54

-0.06 (-0.18%)

10:24
11/19/19
11/19
10:24
11/19/19
10:24
Conference/Events
NCR Corp. management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

MSFT

Microsoft

$150.39

0.04 (0.03%)

10:23
11/19/19
11/19
10:23
11/19/19
10:23
Hot Stocks
Microsoft executive says Teams now has 20M daily active users »

Jared Spataro, Corporate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.